Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
R&D Systems™ Human IFN-gamma Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 285IF100/CF
This item is not returnable. View return policy
SDSDocumentsProduct Certifications Promotions
DescriptionMeasured in anti-viral assays using HeLa human cervical epithelial carcinoma cells infected with encephalomyocarditis (EMC) virus. Meager, A. (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. et al. (eds): IRL Press. 129. The ED50 for this effect is 0.15-0.75 ng/mL. The specific activity of Recombinant Human IFN-gamma is approximately 2 x 104 IU/μg, which is calibrated against human IFN-gamma Standard (NIBSC code: 87/586). Specific activity is for reference purposes only and is not routinely tested.
|Lyophilized from a 0.2μm filtered solution in Sodium Succinate, Mannitol and Tween™ 80.|
|97%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|E. coli-derived human IFN-gamma protein Gln24-Gln166 with an N-terminal Met|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok